Free Trial

Sonnet BioTherapeutics (SONN) SEC Filings & 10K Form

Sonnet BioTherapeutics logo
$1.54 0.00 (0.00%)
As of 01/21/2025 04:00 PM Eastern

Recent Sonnet BioTherapeutics SEC Filings

DateFilerForm TypeView
01/13/2025
3:34 PM
Sonnet BioTherapeutics (Filer)
Form POS AM
12/23/2024
3:05 PM
Sonnet BioTherapeutics (Filer)
Form D
Notice of Exempt Offering of Securities 
12/17/2024
8:00 AM
Sonnet BioTherapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
12/17/2024
7:50 AM
Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/10/2024
8:25 AM
Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/10/2024
8:20 AM
Sonnet BioTherapeutics (Filer)
Form 424B5
12/09/2024
7:50 AM
Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/05/2024
8:55 PM
Cross John Harry III (Reporting)
Sonnet BioTherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2024
8:55 PM
Kenney Richard T (Reporting)
Sonnet BioTherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2024
8:55 PM
Mohan Pankaj (Reporting)
Sonnet BioTherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2024
8:55 PM
Griffith Donald J. (Reporting)
Sonnet BioTherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2024
8:55 PM
Cini John K. (Reporting)
Sonnet BioTherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2024
8:55 PM
Rao Raghu (Reporting)
Sonnet BioTherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2024
8:55 PM
Dyrness Albert D. (Reporting)
Sonnet BioTherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2024
8:55 PM
McNeill Lori (Reporting)
Sonnet BioTherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2024
8:55 PM
Dexter Susan (Reporting)
Sonnet BioTherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2024
8:55 PM
Bhatt Nailesh (Reporting)
Sonnet BioTherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2024
8:20 AM
Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/26/2024
4:15 PM
Sonnet BioTherapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
11/08/2024
7:30 AM
Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/07/2024
8:22 AM
Sonnet BioTherapeutics (Filer)
Form 424B4
11/06/2024
11:15 PM
Sonnet BioTherapeutics (Filer)
Form EFFECT
11/06/2024
8:22 AM
Sonnet BioTherapeutics (Filer)
Form S-1/A
11/06/2024
7:48 AM
Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/04/2024
8:01 AM
Sonnet BioTherapeutics (Filer)
Form S-1/A
10/28/2024
8:01 AM
Sonnet BioTherapeutics (Filer)
Form S-1
Registration statement under Securities Act of 1933  
10/17/2024
7:50 AM
Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/09/2024
7:56 AM
Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/30/2024
7:30 AM
Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/18/2024
7:36 AM
Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/12/2024
4:15 PM
Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/30/2024
7:30 AM
Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/19/2024
4:27 PM
Sonnet BioTherapeutics (Filer)
Form DEF 14A
08/19/2024
4:28 PM
Sonnet BioTherapeutics (Filer)
Form ARS
08/19/2024
7:50 AM
Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2024
7:41 AM
Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2024
7:45 AM
Sonnet BioTherapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/09/2024
4:28 PM
Sonnet BioTherapeutics (Filer)
Form PRE 14A
07/24/2024
7:36 AM
Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/15/2024
11:15 PM
Sonnet BioTherapeutics (Filer)
Form EFFECT
07/15/2024
4:05 PM
Sonnet BioTherapeutics (Filer)
Form 424B3
Kamala’s final humiliation (Ad)

Now, for the first time, I’m going to share these ten investments publicly – the same ones I’ve discussed behind closed doors with some of America’s savviest investors. The obscure, little-known companies we believe could 5x, even 10x, under Trump’s second term…

07/05/2024
3:06 PM
Sonnet BioTherapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
06/20/2024
3:49 PM
Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/13/2024
7:15 AM
Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/22/2024
6:35 AM
Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/20/2024
8:25 AM
Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/16/2024
11:15 PM
Sonnet BioTherapeutics (Filer)
Form EFFECT
05/14/2024
4:25 PM
Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/03/2024
7:30 AM
Sonnet BioTherapeutics (Filer)
Form S-1
Registration statement under Securities Act of 1933  
05/03/2024
7:00 AM
Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/11/2024
6:30 AM
Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/06/2024
3:20 PM
Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2024
6:35 AM
Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2024
6:30 AM
Sonnet BioTherapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:SONN) was last updated on 1/22/2025 by MarketBeat.com Staff
From Our Partners